Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (11)

2021

  1. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  2. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

  3. Igf1r as a potential pharmacological target in allergic asthma

    Biomedicines, Vol. 9, Núm. 8

2015

  1. Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21

    International Journal of Cancer, Vol. 136, Núm. 10, pp. 2427-2436

2013

  1. Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene

    European Journal of Cancer, Vol. 49, Núm. 2, pp. 474-481

2009

  1. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: A two-stage Spanish case-control study

    Gynecologic Oncology, Vol. 112, Núm. 1, pp. 210-214

2008

  1. The ‘Pokemon’ (ZBTB7) gene: No evidence of association with sporadic breast cancer

    Clinical Medicine: Oncology, Vol. 2, pp. 357-362

2006

  1. Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: A Spanish case-control study

    International Journal of Cancer, Vol. 119, Núm. 2, pp. 467-471

2005

  1. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study

    Oncology Reports, Vol. 14, Núm. 6, pp. 1527-1531

2004

  1. Influence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin's Lymphoma Study Group

    Journal of Clinical Oncology, Vol. 22, Núm. 9, pp. 1664-1673

  2. The variant E233G of the rad51d gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations

    International Journal of Cancer, Vol. 110, Núm. 6, pp. 845-849